Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts.
Abstract
[BACKGROUND] Machine perfusion is gaining interest as an efficient method of tissue preservation of Vascularized Composite Allografts (VCA). The aim of this study was to develop a protocol for ex vivo subnormothermic oxygenated machine perfusion (SNMP) on rodent hindlimbs and to validate our protocol in a heterotopic hindlimb transplant model.
[METHODS] In this optimization study we compared three different solutions during 6 h of SNMP (n = 4 per group). Ten control limbs were stored in a preservation solution on Static Cold Storage [SCS]). During SNMP we monitored arterial flowrate, lactate levels, and edema. After SNMP, muscle biopsies were taken for histology examination, and energy charge analysis. We validated the best perfusion protocol in a heterotopic limb transplantation model with 30-d follow up (n = 13). As controls, we transplanted untreated limbs (n = 5) and hindlimbs preserved with either 6 or 24 h of SCS (n = 4 and n = 5).
[RESULTS] During SNMP, arterial outflow increased, and lactate clearance decreased in all groups. Total edema was significantly lower in the HBOC-201 group compared to the BSA group (P = 0.005), 4.9 (4.3-6.1) versus 48.8 (39.1-53.2) percentage, but not to the BSA + PEG group (P = 0.19). Energy charge levels of SCS controls decreased 4-fold compared to limbs perfused with acellular oxygen carrier HBOC-201, 0.10 (0.07-0.17) versus 0.46 (0.42-0.49) respectively (P = 0.002).
[CONCLUSIONS] Six hours ex vivo SNMP of rodent hindlimbs using an acellular oxygen carrier HBOC-201 results in superior tissue preservation compared to conventional SCS.
[METHODS] In this optimization study we compared three different solutions during 6 h of SNMP (n = 4 per group). Ten control limbs were stored in a preservation solution on Static Cold Storage [SCS]). During SNMP we monitored arterial flowrate, lactate levels, and edema. After SNMP, muscle biopsies were taken for histology examination, and energy charge analysis. We validated the best perfusion protocol in a heterotopic limb transplantation model with 30-d follow up (n = 13). As controls, we transplanted untreated limbs (n = 5) and hindlimbs preserved with either 6 or 24 h of SCS (n = 4 and n = 5).
[RESULTS] During SNMP, arterial outflow increased, and lactate clearance decreased in all groups. Total edema was significantly lower in the HBOC-201 group compared to the BSA group (P = 0.005), 4.9 (4.3-6.1) versus 48.8 (39.1-53.2) percentage, but not to the BSA + PEG group (P = 0.19). Energy charge levels of SCS controls decreased 4-fold compared to limbs perfused with acellular oxygen carrier HBOC-201, 0.10 (0.07-0.17) versus 0.46 (0.42-0.49) respectively (P = 0.002).
[CONCLUSIONS] Six hours ex vivo SNMP of rodent hindlimbs using an acellular oxygen carrier HBOC-201 results in superior tissue preservation compared to conventional SCS.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | hindlimbs
|
scispacy | 1 | ||
| 해부 | hindlimb
|
scispacy | 1 | ||
| 해부 | limbs
|
scispacy | 1 | ||
| 해부 | acellular oxygen carrier HBOC-201,
|
scispacy | 1 | ||
| 해부 | acellular oxygen carrier HBOC-201 results
|
scispacy | 1 | ||
| 합병증 | edema
|
scispacy | 1 | ||
| 합병증 | muscle biopsies
|
scispacy | 1 | ||
| 합병증 | heterotopic limb
|
scispacy | 1 | ||
| 합병증 | arterial outflow
|
scispacy | 1 | ||
| 약물 | lactate
|
C0022924
Lactates
|
scispacy | 1 | |
| 약물 | PEG
|
C0032483
polyethylene glycols
|
scispacy | 1 | |
| 약물 | oxygen
|
C0030054
oxygen
|
scispacy | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | edema
|
C0013604
Edema
|
scispacy | 1 | |
| 질환 | SNMP
→ subnormothermic oxygenated machine perfusion
|
scispacy | 1 | ||
| 기타 | VCA
→ Vascularized Composite Allografts
|
scispacy | 1 | ||
| 기타 | arterial
|
scispacy | 1 | ||
| 기타 | SNMP
→ subnormothermic oxygenated machine perfusion
|
scispacy | 1 | ||
| 기타 | SCS
|
scispacy | 1 |
MeSH Terms
Allografts; Animals; Composite Tissue Allografts; Extremities; Organ Preservation; Oxygen; Perfusion